Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy

Autor: Sebastiaan Remmers, Daan Nieboer, L. Lucia Rijstenberg, Tim Hansum, Geert J.L.H. van Leenders, Monique J. Roobol

Publikováno v: European Urology Open Science, Vol 36, Iss , Pp 19-22 (2022)

The Rotterdam Prostate Cancer Risk Calculator (RPCRC) is a well-validated tool for upfront risk stratification to reduce the number of prostate biopsies and magnetic resonance imaging scans among both biopsy-naïve and previously biopsied men. The pr

Externí odkaz: https://doaj.org/article/b15f1d4e73a8406db7ce020eb7013926

Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma

Autor: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, Michiel S. van der Heijden, Jens Voortman, Edwin Cuppen, Niven Mehra, Sandra van Wilpe, Sjoukje F. Oosting, L. Lucia Rijstenberg, Hans M. Westgeest, Ellen C. Zwarthoff, Ronald de Wit, Astrid A.M. van der Veldt, Harmen J.G. van de Werken, Martijn P.J. Lolkema, Joost L. Boormans

Publikováno v: Nakauma-González, J A, Rijnders, M, van Riet, J, van der Heijden, M S, Voortman, J, Cuppen, E, Mehra, N, van Wilpe, S, Oosting, S F, Rijstenberg, L L, Westgeest, H M, Zwarthoff, E C, de Wit, R, van der Veldt, A A M, van de Werken, H J G, Lolkema, M P J & Boormans, J L 2022, ' Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma ', European Urology, vol. 81, no. 4, pp. 331-336 . https://doi.org/10.1016/j.eururo.2022.01.026
European Urology, 81(4), 331-336. Elsevier
European Urology, 81(4), 331-336. ELSEVIER SCIENCE BV
European Urology, 81, 331-336
European Urology, 81, 4, pp. 331-336

Contains fulltext : 249819.pdf (Publisher’s version ) (Open Access) Recent molecular characterization of primary urothelial carcinoma (UC) may guide future clinical decision-making. For metastatic UC (mUC), a comprehensive molecular characterizatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0254ca9ff84291d08024ee4f29df83e3
https://doi.org/10.1016/j.eururo.2022.01.026

Hyperspectral Imaging for Tissue Classification after Advanced Stage Ovarian Cancer Surgery

Autor: Sharline M. van Vliet-Pérez, Nick J. van de Berg, Francesca Manni, Marco Lai, Lucia Rijstenberg, Benno H. W. Hendriks, Jenny Dankelman, Patricia C. Ewing-Graham, Gatske M. Nieuwenhuyzen-de Boer, Heleen J. van Beekhuizen

Publikováno v: Cancers; Volume 14; Issue 6; Pages: 1422
Cancers, 14(6)
Cancers, 14(6):1422. Multidisciplinary Digital Publishing Institute (MDPI)

The most important prognostic factor for the survival of advanced-stage epithelial ovarian cancer (EOC) is the completeness of cytoreductive surgery (CRS). Therefore, an intraoperative technique to detect microscopic tumors would be of great value. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792c0b8db3af8444c32c292df4ffee3b
https://doi.org/10.3390/cancers14061422

Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population

Autor: Renée M. F. Ebisch, L. Lucia Rijstenberg, Gilda Ghazi Soltani, Judith van der Horst, Judith E. M. Vedder, Meyke Hermsen, Remko P. Bosgraaf, Leon F. A. G. Massuger, Chris J. L. M. Meijer, Daniëlle A. M. Heideman, Folkert J. van Kemenade, Willem J. G. Melchers, Ruud L. M. Bekkers, Albert G. Siebers, Johan Bulten

Publikováno v: Acta Obstetricia et Gynecologica Scandinavica, 101(11), 1328-1336. Wiley-Blackwell
Ebisch, R M F, Rijstenberg, L L, Soltani, G G, van der Horst, J, Vedder, J E M, Hermsen, M, Bosgraaf, R P, Massuger, L F A G, Meijer, C J L M, Heideman, D A M, van Kemenade, F J, Melchers, W J G, Bekkers, R L M, Siebers, A G & Bulten, J 2022, ' Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population ', Acta Obstetricia et Gynecologica Scandinavica, vol. 101, no. 11, pp. 1328-1336 . https://doi.org/10.1111/aogs.14459
Acta Obstetricia et Gynecologica Scandinavica, 101, 1328-1336
Acta Obstetricia et Gynecologica Scandinavica, 101, 11, pp. 1328-1336
Acta Obstetricia et Gynecologica Scandinavica, 101(11), 1328-1336. Wiley

Contains fulltext : 288072.pdf (Publisher’s version ) (Open Access) INTRODUCTION: Immunostaining with p16(INK4a) (p16), a tumor-suppressor surrogate protein biomarker for high-risk human papillomavirus (hrHPV) oncogenic activity, may complement sta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778cb9f5a98b03b056fb6127c2f78c26
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/288072

Abstract 2190: Integrative genomic and transcriptomic characterization of metastatic urothelial carcinoma

Autor: Edwin Cuppen, Sandra van Wilpe, Job van Riet, Jens Voortman, Martijn P. Lolkema, Harmen J.G. van de Werken, E.C. Zwarthoff, Joost L. Boormans, Michiel S. van der Heijden, Astrid A.M. van der Veldt, Niven Mehra, Ronald de Wit, L. Lucia Rijstenberg, Maud Rijnders, J. Alberto Nakauma-Gonzalez, Sjoukje F. Oosting

Publikováno v: Cancer Research. 81:2190-2190

Metastatic urothelial carcinoma (mUC) is a lethal cancer with limited therapeutic options available. To identify novel targets for therapy, large-scale sequencing efforts are needed. The Cancer Genome Atlas (TCGA) initiative substantially improved ou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b68516c8ca5d1508f1bdd73e2cd4fd8
https://doi.org/10.1158/1538-7445.am2021-2190